Praxis Precision Medicines, Inc. PRAX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s accrued expenses?
- Praxis Precision Medicines, Inc. (PRAX) reported accrued expenses of $17.65M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s accrued expenses changed year-over-year?
- Praxis Precision Medicines, Inc.'s accrued expenses increased by 13.5% year-over-year, from $15.55M to $17.65M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s accrued expenses has grown at a 26.4% compound annual growth rate (CAGR), from $10.87M to $35.03M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.